EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

Cancer Immunology Research

ISSN 2326-6066 · American Association for Cancer Research (AACR)

Neueste Artikel

  1. Lower Airway Microbiome Transcriptional and Metabolic Activities Influence Responsiveness to Immunotherapy in NSCLC

    Fares Darawshy, Jun-Chieh J. Tsay, Elizabeth Sanchez, Dong-Min Jin, Yeji Kim, Qingsheng Li, Matthew Chung, Anton S. Becker, Imran Sulaiman, Clea Barnett, Benjamin G. Wu, Ray Pillai, Benjamin Kwok, Kendrew K. Wong, Matthias C. Kugler, Yonghua Li, Rosemary Schluger, Destiny Collazo, Yaa Kyeremateng, Alexander Bain, Miao Chang, Jamie L. Bessich, Andrew DeMaio, Isaac Laniado, Daniel K. O’Neill, Elaine Shum, Abraham Chachoua, John J. Hall, Jonathan Sanders, George Thurston, Marcus D. Goncalves, Ezequiel C. Dantas, Rami S. Vanguri, Kwok-Kin Wong, Daniel H. Sterman, Aristotelis Tsirigos, James Morton, Huilin Li, Elodie Ghedin, Leopoldo N. Segal

    Erschienen: 2026-11-12DOI: 10.1158/2326-6066.cir-26-0433

  2. Disruption of the CRL5 Ubiquitin Ligase Complex Enhances Engineered T-cell Persistence under Chronic Tumor Antigen Exposure

    Stefanie Bachl, Carter Ching, Alexis Talbot, Antoine Forget, Nupura Kale, Clara Kochendoerfer, William A. Nyberg, Zhongmei Li, Peixin Amy Chen, Patrick H. Kennedy, Qi Liu, Joseph J. Muldoon, Chang Liu, Gwendolyn Cusing, Nadia Arang, Nevan J. Krogan, Greg M. Allen, Alexander Marson, Stacie E. Dodgson, Justin Eyquem, Julia Carnevale

    Erschienen: 2026-11-12DOI: 10.1158/2326-6066.cir-26-0608

  3. Engineered stem cell-derived CD16-enhanced universal NKT cells improve monoclonal antibody-based cancer immunotherapy

    Yan-Ruide Li, Yichen Zhu, Yanqi Yu, Adam Kramer, Zhengyao Shao, Yuning Chen, Xinyuan Shen, Catherine Zhang, Nathan Ma, Annabel Zhao, Christopher J. Ochoa, Gabriella A. DiBernardo, Thomas Yuen, Coral L. Clune, Paulina Dominguez-Vela, Shelby Yeh, Zhaojun Qiu, Jie Huang, Arnold I. Chin, Sarah M. Larson, Caspian Oliai, Sanaz Memarzadeh, Lili Yang

    Erschienen: 2026-11-10DOI: 10.1158/2326-6066.cir-26-0767

  4. TIM3 Blockade with Hypomethylating Therapy Restores NK Cell and Cytotoxic CD4+ T-cell Activity in Patients with AML or MDS

    Jani Huuhtanen, Sofia Forstén, Brittany Ford, Johannes Smolander, Oscar Brück, Sofie Lundgren, Anna Kreutzman, Olli Dufva, Matti Kankainen, Mette Ilander, Hanna Lähteenmäki, Tiina Kasanen, Jay Klievink, Judith Leitner, Peter Steinberger, Mika Kontro, Marc R. Pelletier, Harri Lähdesmäki, Catherine Sabatos-Peyton, Mikael L. Rinne, Kimmo Porkka, Karita Peltonen, Satu Mustjoki

    Erschienen: 2026-11-03DOI: 10.1158/2326-6066.cir-26-0160

  5. Neutralizing the IL12/IL23 p40 Subunit Prevents Immune Checkpoint Blockade Toxicity without Compromising Antitumor Efficacy

    Christianne Groeneveldt, Disha Vadgama, Anne Onrust-van Schoonhoven, Declan Whyte, Maaike M. Hofman, Nina E.M. Rozendaal, Menno van Nimwegen, Mike Eterman, Daphne W. Dumoulin, Ron H.J. Mathijssen, Arjen Joosse, Astrid A.M. van der Veldt, Louis Boon, Michail Doukas, Janneke N. Samsom, Ralph Stadhouders, Floris Dammeijer, Joachim G.J.V. Aerts, Maria E. Joosse

    Erschienen: 2026-11-03DOI: 10.1158/2326-6066.cir-26-0177

  6. Immune Checkpoint Blockade Sensitivity Is Linked to Endogenous Retroelement Transcriptional Changes in Cancer

    Mercedes Herrera, Sajid A. Marhon, Zhihui Amy Liu, Helen Loo, Farnoosh Abbas-Aghababazadeh, Jeff P. Bruce, David Chen, Emily Van de Laar, Helen Chow, Philippe L. Bedard, Albiruni R. Abdul Razak, Anna Spreafico, Marcus O. Butler, Stephanie Lheureux, Trevor J. Pugh, Benjamin Haibe-Kains, Lillian L. Siu, Daniel D. De Carvalho, Pavlina Spiliopoulou

    Erschienen: 2026-11-03DOI: 10.1158/2326-6066.cir-26-0365

  7. The Posttranscriptional Regulator HuR Promotes Immune Evasion in Pancreatic Ductal Adenocarcinoma

    Yifei Guo, Jennifer M. Finan, Alexandra Q. Bartlett, Katherine R. Pelz, Shamilene Sivagnanam, Katie E. Blise, Nell Kirchberger, Konjit Betre, Yuhui Wei, Jennifer R. Eng, Vidhi M. Shah, Koei Chin, Grace A. McCarthy, Hen Halamish, Kevin MacPherson-Hawthorne, Colin J. Daniel, Canping Chen, Aaron J. Grossberg, Zheng Xia, Sha Cao, Lisa M. Coussens, Rosalie C. Sears, Jonathan R. Brody, Robert Eil

    Erschienen: 2026-11-03DOI: 10.1158/2326-6066.cir-26-0472

  8. Addition of Chemotherapy to Radiotherapy Promotes Progenitor-Exhausted CD8+ T-cell Clonal Dominance in Head and Neck Cancer

    Charleen Chan Wah Hak, Anton Patrikeev, Antonio Rullan, Emmanuel C. Patin, Victoria Roulstone, Lisa C. Hubbard, Matthew Guelbert, Elizabeth S. Appleton, Shane Foo, Isaac Dean, Amy Burley, Joan N. Kyula-Currie, Holly Baldock, Jen Y. Lee, Pablo Nenclares, Hannah Nanapragasam, Carmen Murano, Malin Pedersen, Maggie Chon U. Cheang, Shreerang A. Bhide, Masahiro Ono, Kevin J. Harrington, Alan A. Melcher

    Erschienen: 2026-11-03DOI: 10.1158/2326-6066.cir-26-0706

  9. ULK1-Dependent Autophagy Initiation Promotes MHC-I Degradation and Immune Evasion in HPV-Positive Head and Neck Cancer

    Lexi Vu, Nicholas S. Giacobbi, Mohamed I. Khalil, Canchai Yang, William J. Eckerman, Evelyn D. Gomez Recinos, Johnathon D. Garber, Abigail Z. Bennett, Bryttan Adams, Hyomin Son, Prerna Chahal, Dara M. Villa, Tanisha Srivastava, Katie R. Martin, Craig C. Welbon, Caitlin S. Williamson, William C. Spanos, Jeffrey P. MacKeigan, Andrew J. Olive, Dohun Pyeon

    Erschienen: 2026-11-02DOI: 10.1158/2326-6066.cir-26-0421

  10. Inducible IL12- or IL18-Secreting CAR T Cells Targeting the Glyco-antigen CD176 Exhibit Potent Activity against Non–Small Cell Lung Cancer in Preclinical Models

    Chiara Malinconico, Justus Weber, Antonina Jana Polzien, Agnes Bonifacius, Melina Umland, Quentin Deveuve, Tonia Bargmann, Katharina Zimmermann, Johanna Gellert, Lavinia Neubert, Stefan Dübel, Axel Schambach, Armin Braun, Rainer Blasczyk, Hinrich Abken, Michael Hudecek, Anna Christina Dragon, Britta Eiz-Vesper

    Erschienen: 2026-10-29DOI: 10.1158/2326-6066.cir-25-1399

Jahrgänge

2026 · 3642025 · 2232024 · 1432023 · 1402022 · 2432021 · 2382020 · 5792019 · 6352018 · 2982017 · 2742016 · 7722015 · 3252014 · 1362013 · 56

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.